EP Patent

EP3028709A1 — Oral b12 therapy

Assigned to Emisphere Technologies Inc · Expires 2016-06-08 · 10y expired

What this patent protects

Methods of normalizing vitamin B 12 levels in patients with low vitamin B 12 and methods of normalizing intersubject variability in the treatment of such patients are described. Methods of reducing MMA and/or homocysteine levels, and pharmaceutical compositions useful to effect…

USPTO Abstract

Methods of normalizing vitamin B 12 levels in patients with low vitamin B 12 and methods of normalizing intersubject variability in the treatment of such patients are described. Methods of reducing MMA and/or homocysteine levels, and pharmaceutical compositions useful to effect such changes are also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP3028709A1
Jurisdiction
EP
Classification
—
Expires
2016-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Emisphere Technologies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.